These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 28434305)
21. Inotersen for the Treatment of Hereditary Transthyretin Amyloidosis. Mahfouz M; Maruyama R; Yokota T Methods Mol Biol; 2020; 2176():87-98. PubMed ID: 32865784 [TBL] [Abstract][Full Text] [Related]
22. Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis. Benson MD; Waddington-Cruz M; Berk JL; Polydefkis M; Dyck PJ; Wang AK; Planté-Bordeneuve V; Barroso FA; Merlini G; Obici L; Scheinberg M; Brannagan TH; Litchy WJ; Whelan C; Drachman BM; Adams D; Heitner SB; Conceição I; Schmidt HH; Vita G; Campistol JM; Gamez J; Gorevic PD; Gane E; Shah AM; Solomon SD; Monia BP; Hughes SG; Kwoh TJ; McEvoy BW; Jung SW; Baker BF; Ackermann EJ; Gertz MA; Coelho T N Engl J Med; 2018 Jul; 379(1):22-31. PubMed ID: 29972757 [TBL] [Abstract][Full Text] [Related]
23. The transthyretin amyloidoses: advances in therapy. Dubrey S; Ackermann E; Gillmore J Postgrad Med J; 2015 Aug; 91(1078):439-48. PubMed ID: 26048914 [TBL] [Abstract][Full Text] [Related]
24. Efficiency of silencing RNA for removal of transthyretin V30M in a TTR leptomeningeal animal model. Gonçalves P; Martins H; Costelha S; Maia LF; Saraiva MJ Amyloid; 2016 Dec; 23(4):249-253. PubMed ID: 27884058 [TBL] [Abstract][Full Text] [Related]
25. Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study. Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G Amyloid; 2019; 26(sup1):26. PubMed ID: 31343346 [No Abstract] [Full Text] [Related]
26. siRNA therapy improves multimodality imaging in hereditary transthyretin cardiac amyloidosis: a case report. Awaya T; Endo J; Iijima R; Shimoda M; Moroi M QJM; 2024 Apr; 117(4):304-306. PubMed ID: 38229248 [No Abstract] [Full Text] [Related]
27. Treatment of transthyretin cardiomyopathy with a TTR-specific antisense oligonucleotide (IONIS-TTR Benson MD; Ackermann EJ; Monia BP Amyloid; 2017 Mar; 24(sup1):134-135. PubMed ID: 28434337 [No Abstract] [Full Text] [Related]
28. Response by Solomon to Letter Regarding Article, "Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study". Solomon SD Circulation; 2019 Jul; 140(2):e92-e93. PubMed ID: 31283371 [No Abstract] [Full Text] [Related]
29. From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis. Russo M; Gentile L; Toscano A; Vita G; Mazzeo A Amyloid; 2020 Dec; 27(4):279-280. PubMed ID: 32515606 [No Abstract] [Full Text] [Related]
30. Gene therapy: lessons learned from liver transplantation for transthyretin-amyloidosis. Suhr OB; Holmgren G; Lundgren E Liver Transpl; 2004 Dec; 10(12):1551-3. PubMed ID: 15558840 [No Abstract] [Full Text] [Related]
32. Letter by González-Costello et al Regarding Article, "Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-mediated Amyloidosis: Analysis of the APOLLO Study". González-Costello J; Casasnovas C; Díez-López C Circulation; 2019 Jul; 140(2):e90-e91. PubMed ID: 31283374 [No Abstract] [Full Text] [Related]
33. Selective silencing of a mutant transthyretin allele by small interfering RNAs. Kurosawa T; Igarashi S; Nishizawa M; Onodera O Biochem Biophys Res Commun; 2005 Nov; 337(3):1012-8. PubMed ID: 16225852 [TBL] [Abstract][Full Text] [Related]
34. Recent progress in the understanding and treatment of transthyretin amyloidosis. Sekijima Y J Clin Pharm Ther; 2014 Jun; 39(3):225-33. PubMed ID: 24749898 [TBL] [Abstract][Full Text] [Related]
35. Amyloidotic breast nodule in hereditary transthyretin amyloidosis (hATTR): a case report. Cisneros-Barroso E; Losada-López I; González-Moreno J; Buades J; Ferrer-Nadal A; Ripoll-Vera T; Usón M; Figuerola A; Montalà JC; Descals C; Salva-Ramonell F; Torres-Rovira J; Gene-Heym A; Fernández-Burgos I; Soler T Amyloid; 2019; 26(sup1):59-60. PubMed ID: 31343326 [No Abstract] [Full Text] [Related]